Novo Nordisk has told the world it expects patients to lose “at least 25%” of their body weight on its experimental drug ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

It was one of the Danish pharma giant's worst days on the stock market, as its shares fell by up to 29 per cent. The company ...

Weight loss with Ozempic or Wegovy can come with nausea, but avoiding certain foods and drinks can help patients manage the ...

Since Ozempic blasted onto the stage in 2017 with its approval for type 2 diabetes, drugmakers Novo Nordisk and Eli Lilly ...

Reversal or remission is the hope.

The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.

For an upcoming article, we are looking for stories about what happens to a long-term relationship when one partner decides ...

Signs at AMPAC Fine Chemicals' location in the Petersburg Industrial Park have already been changed to 'Novo Nordisk' in advance of the acquisition ...

自诺和诺德的重磅糖尿病药物Ozempic于2017年在美国获得批准以来，孟加拉国、老挝、俄罗斯和巴拉圭的监管机构已批准了 22 种含有其主要成分的药物，孟加拉国还批准了礼来药物的7种仿制药。 Ozempic的专利成分司美格鲁肽(Semaglutide ...

We’ve rounded up the biggest things we learned about our health this year – and what the experts had to say about them.